London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Good to see some info on this one , like JQW recommended to me by SVS securitys.
Looks like another complete loss ?
Saw this about China investments .
China Pacific Insurance to press on with London listing under connect scheme
By Carolyn Cohn and Oliver Hirt
LONDON/ZURICH, June 2 (Reuters) - China Pacific Insurance
<601601.SS> is pressing ahead with a London listing under a
stock link scheme between Britain and China, it said on Tuesday,
defying the market turmoil wrought by COVID-19.
The Chinese insurer, which is seeking to raise cash to
support its overseas expansion, said it would issue 125.7
million units of global depositary receipts (GDR) in London with
Swiss Re as its cornerstone investor.
Swiss Re will take a GDR allotment of up to 1.5% of China
Pacific's total number of ordinary shares, with a lock-up period
of three years.
The Shanghai-London Stock Connect scheme, which allows
Chinese companies to add a secondary GDR listing in Britain, was
first announced in 2018. It was meant to herald a flurry of
Chinese listings in London but so far only one has materialised,
the Huatai Securities brokerage deal last year. [nL8N23O1LL]
SDIC, which was set to become the second Chinese company to
make use of the scheme, called off its London listing in
December, blaming market conditions.
The U-turn prompted speculation among bankers and analysts
that China Pacific Insurance could follow suit due to the market
turbulence caused by the coronavirus pandemic. [nL8N2D10HM]
But China wants to revive the link scheme as a way to
strengthen overseas ties and fund its post-lockdown recovery.
Beside China Pacific Insurance, energy firms SDIC Power
<600886.SS> and China Yangtze Power <600900.SS> have also
received the go-ahead from Beijing to list GDRs in London,
sources have said. [nL8N2D10HM]
If successful, these listings will give a boost to the
London Stock Exchange where share sales have come to a halt due
to the business paralysis caused by the spread of the virus.
European listings raised $918 million in the first quarter
of 2020, according to Refinitiv data, more than three times the
$301.2 million in the year earlier period. But activity halted
abruptly in March and only partly resumed in May with coffee
maker JDE Peet making its market debut in Amsterdam.
(Reporting by Carolyn Cohn in London and Oliver Hirt in Zurich;
Editing by Pamela Barbaglia and Pravin Char)
((firstname.lastname@example.org; 44 207 542 6320; Reuters
too true bignose.I'm reminded more of a film with slight modification...nightmare on regent street
That will be the norm until JG is sacked for incompetence, China pays its wonga, EU sales go through the roof and a US licensee buys the product outright for at least 300mill squidaroonies.. That reminds me of a lyric from one of ABBA's song..."I had a dream...." LOL
oh god bignose.iwas feeling pretty depressed when i posted and now you mention profit warning is there no relief!lol
I'd guess someone just selling out, although its really difficult to understand how when no one is buying. matched sells and buys and all that.
If one had spare cash and had invested around mid march they'd be up over 100% (take BOO for example that's over 200% up). Games workshop is another and even ASOS. Just amazing how share prices are manipulated by the city boys at a touch of a button since none of these companies saw anywhere near the number of shares required to drop them by that much. The whole system is corrupt. There was no reason, apart from running scared, that within 6 weeks BOO's value dropped from about 3.6 billion to under 1 billion and now its back up to 4.5 billion. Tell me I'm wrong.
In expectation of yet another profit warning in a months time. And still JG is getting his 125k monthly salary.
107 sells.mostly tiny. overall volume not very much.most trades i've seen for a while.
Bothwell, a sensible decision. This (three, five year old?) "report" is only of use if printed on Andrex.
Looking at the blurb, Bayer and Lilly are presumably mentioned on the basis of their respective ED drugs being used off label for PE treatment. Neither has ever dipped into PE research. No mention of Menarini, which markets the only near-globally approved PE treatment, dapoxetine, for over a decade (after J&J giving up on it).
GSK and Pfizer both had early oral drug programmes, both abandoned about 15 years back. An abandoned Pfizer candidate was resurrected by a UK start up, Ixchelsis (Dr W's ex-workmates), but bombed out in Phase II. The Dong A Pharma (no s******ing at the back) oral SSRI candidate was abandoned five years back. A Turkish generics company has trialled and published on a fixed dose sildenafil-dapoxetine tablet in concurrent ED and PE (now recruiting for Phase III studies).
Of the monograph desensitiser merchants, Absorption does about $3m in Promescent sales (and a bit from OEM), Pre-Boost wipes (branded and OEM) under a $1m, Stud 100 about $0.5m before rights were sold (as wholesale transfer price- 5-10 fold more as retail). A lidocaine-prilocaine spray was approved and launched in India almost 10 years ago (since discontinued). A Futura-developed spray was launched by Ansell in the US over six years with next to zero sales.
I wonder if RP has ever shelled out for a copy? This would go some way to explain the company's complete lack of understanding of the PE market.
And a last minute buy at 15:48 of one truck load of 10k and its back where it started....talk about manipulation.
hello bignose.thanks for that .yes thought they sold some but hadn't checked.just posting out of frustation really. im sure you know how it is. i think the price of venturex had been in decline for quite a while but i only check occasionally.as you suggest i don't suppose the sale helped.yes quite worrying about h/k.i expect china feels under more threat after covid than before and may be less tolerant of dissent in h/k.i do hope we don't see an exodus of companies and hope that china will not force a situation which results in that, but it may happen.china is probably going to emerge from all this in a stronger position so may be prepared to allow h/k to decline, although i hope not.we shall see.small trades again today and we were down several % right until the final buy trade. nothing significant really.
They did offload some to go towards it. It surely cannot be just the C-19 that made such a significant drop....maybe it was the selling that did it.....LOL.
Not looking good for HK now. It wont be long before it becomes part of the whole, but will that cause a mass exodus of all listed companies. Maybe that's what RPG meant by more liquidity........all companies leaving and no longer any point in keeping the HKSX....... :-)
street protests again now as predicted.not suggesting its going to have a major impact on regents s/p but its not an ideal backdrop for the hk market in general.
you will remember when we all thought they were going to sell venturex to pay the tax. on the 24 th may 2019 it was 0.19 AD.now 0.07 AD.not sure how much of that fall is covid related but remind me not to pay too much attention to heimdal with his eulogising about its prospects .could recover of course but we need to bear in mind it was a substantial asset at one stage .
hello bothwell no I'm not paying for it either although it would be good to see what it says.not sure it would be good value though as it refers to futura medical ,which so far as i am aware is no longer pursuing avenues in the PE field but is concentrating on ED. it did, i understand, have a PE product but that was discontinued and it is now concentrating on an ED product (it also has a topical pain relief product and a very early stage collaboration for a cannabidiol delivery system). perhaps as you suggest we might get some insight from other posters. incidentally did we have a similar report last year or am i imagining it?
I am not paying $3500 for the report. I wonder if anyone can get access to it so we can better understand how Regent Pacific are placed in PE market.
what i was musing over dougie was the fact that the hang sent fell 5.56% today over fears of china introducing a new and possibly draconian security law which might reignite the rioting etc of a while ago .todays volume was very low again but with quite a number of very small trades which i felt might be small holders just getting out, hence our slightly greater fall.just musing out loud in the absence of anything concrete to talk about.i should probably know better.cheers
what do you mean italian? any idea how this price moves so much on small volumes?
small flight to safety after fears over chinese crackdown perhaps?
carrying on with the power washing.lol
well bignose from my position safely on the ground (my wife is outside carrying on. she actually enjoys it,i less so ) thanks for mentioning N4P.i will certainly have a look at it although I'm trying to be more risk averse after a couple of pretty unpleasant investment setbacks.fum obiiously very risky but i only have a very small amount in it (from the way its going today i wish i had more)but it does have a couple more strings to its bow in the way of topical pain relief and even a very very early stage collaboration for delivery of cannabidiol. they may well come to nothing but after a disaster in one trick pony motif bio i am trying to be a bit more cautious.bizarrely mtfb went up 700% (yes 700)in one day after being linked to covid so certainly money to be made in that area if you can get the timing right.i have followed novacyt but not invested.i wish you luck if you go into N4P and will do a bit of research on it.apologies to other posters for going a bit off topic
Don't end up in a tree. I know they can be pretty powerful....lol
well bothwell its certainly a bit better than for quite few days i think, but still only £15000 or so.still nice to see us up a bit . long way to go I'm afraid.
probably not bothwell,its still tiny really. bignose morning and thanks very much for your post.i will reply in a bit more detail later as I'm power washing the drive .such fun!
Above average volume today. Any significance.
Although you are now also involved with FUM, which I am sure you must have been watching, like me, for sometime, you didn't also happen to consider N4P?
I write this since N4P were also developing an ED product using a reformulation of Sildenafil (active ingredient of Viagra), although in Sept 2018 The Board identified that the risk reward profile to reformulate sildenafil to meet the required drug release profile was too great to continue and they since decided to close the generics division . They now seem to be spending their time and money developing Nuvec, a novel delivery system for vaccines which could be of use in collaborating with other companies developing C-19 vaccines ?
There certainly seems to be a lot of posts on the matter and the company has stated as such too. I see the share price is now heading North and could be a really good opportunity during the next few months if some of the other companies who mentioned C-19 are anything to go by (NCYT for example which has gone up 20 fold in a few weeks). NP4 still has a low market cap (6m) which is peanuts if compared.
I mention it here since it did have an ED product and the company is distantly linked to Dr Mike through, if I remember correctly, one of its employees who also worked at Pfizer. Interestingly Dr Mike did mention to me some years back that he felt the product reformulation wouldn't really be a show stopper since one could just take a Viagra tablet, crush it and rub it on the helmet to get the same effect...... :-)
Anyway, just a thought and maybe of some interest to you. It could also be of interest of a few others here too ?